1. Home
  2. ADAP vs MHH Comparison

ADAP vs MHH Comparison

Compare ADAP & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • MHH
  • Stock Information
  • Founded
  • ADAP 2008
  • MHH 1986
  • Country
  • ADAP United Kingdom
  • MHH United States
  • Employees
  • ADAP N/A
  • MHH N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • MHH Professional Services
  • Sector
  • ADAP Health Care
  • MHH Consumer Discretionary
  • Exchange
  • ADAP Nasdaq
  • MHH Nasdaq
  • Market Cap
  • ADAP 75.5M
  • MHH 87.6M
  • IPO Year
  • ADAP 2015
  • MHH N/A
  • Fundamental
  • Price
  • ADAP $0.25
  • MHH $6.57
  • Analyst Decision
  • ADAP Buy
  • MHH
  • Analyst Count
  • ADAP 6
  • MHH 0
  • Target Price
  • ADAP $1.52
  • MHH N/A
  • AVG Volume (30 Days)
  • ADAP 595.5K
  • MHH 12.6K
  • Earning Date
  • ADAP 08-11-2025
  • MHH 08-06-2025
  • Dividend Yield
  • ADAP N/A
  • MHH N/A
  • EPS Growth
  • ADAP N/A
  • MHH N/A
  • EPS
  • ADAP N/A
  • MHH 0.17
  • Revenue
  • ADAP $179,639,000.00
  • MHH $200,437,000.00
  • Revenue This Year
  • ADAP N/A
  • MHH $1.22
  • Revenue Next Year
  • ADAP $35.48
  • MHH $5.41
  • P/E Ratio
  • ADAP N/A
  • MHH $38.19
  • Revenue Growth
  • ADAP 878.53
  • MHH 3.93
  • 52 Week Low
  • ADAP $0.20
  • MHH $6.20
  • 52 Week High
  • ADAP $1.48
  • MHH $16.00
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 42.09
  • MHH 41.58
  • Support Level
  • ADAP $0.24
  • MHH $6.39
  • Resistance Level
  • ADAP $0.27
  • MHH $6.85
  • Average True Range (ATR)
  • ADAP 0.02
  • MHH 0.40
  • MACD
  • ADAP -0.00
  • MHH 0.04
  • Stochastic Oscillator
  • ADAP 23.57
  • MHH 19.27

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

Share on Social Networks: